FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/05/042507 [Registered on: 12/05/2022] Trial Registered Prospectively
Last Modified On: 10/05/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia
Preventive 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A study to compare the effects of ondansetron and glycopyrrolate to prevent the fall in blood pressure and heart rate following spinal anaesthesia in patients undergoing lower limb orthopaedic surgery 
Scientific Title of Study   A comparative study of prophylactic ondansetron and glycopyrrolate in prevention of spinal induced hypotension and bradycardia in patients undergoing lower limb orthopaedic surgery  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Palas halder 
Designation  PGT 
Affiliation  Calcutta National medical college  
Address  Halisahar new barui para, p.s bizpore,p.o.halisahar,north 24 parganas,west bengal.

North Twentyfour Parganas
WEST BENGAL
713134
India 
Phone  7003669074  
Fax    
Email  dr.palas@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr sudeshna Bhar Kundu 
Designation  Associate professor,Department of anaesthesiology 
Affiliation  Calcutta National medical college  
Address  Baalajee Ganges,Flat no.D304,Bidhan nagar road,kolkata700067,west bengal
Baalajee Ganges,Flat no.D304,Bidhan nagar road,kolkata700067,west bengal
Kolkata
WEST BENGAL
700067
India 
Phone  8777725424  
Fax    
Email  sudeshna04cmc@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Palas halder 
Designation  PGT 
Affiliation  Calcutta National medical college  
Address  Halisahar new barui para, p.s bizpore,p.o.halisahar,north 24 parganas,west bengal.

North Twentyfour Parganas
WEST BENGAL
713134
India 
Phone  7003669074  
Fax    
Email  dr.palas@gmail.com  
 
Source of Monetary or Material Support  
Calcutta National Medical College,32 gorachand road,kolkata-700014,west bengal 
 
Primary Sponsor  
Name  Caicutta National Medical College And Hospital 
Address  32,Gorachand road,kolkata-700014,west bengal 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrPalas Halder  Calcutta national medical college and hospital  32,gorachand road,beniapukur,kolkata-700014,3rd floor,surgery block, Orthopaedic operation theatre
Kolkata
WEST BENGAL 
7003669074

dr.palas@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ETHICS COMMITTEE CAICUTTA NATIONAL MEDICAL COLLEGE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M844||Pathological fracture, not elsewhere classified, (2) ICD-10 Condition: M844||Pathological fracture, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Glycopyrrolate  0.2 mg( diluted to 2 ml normal saline) IV route 5 minute before spinal anaesthesia 
Intervention  Ondansetron  4mg(2 ml) iv route 5 minute brfore spinal anaesthesia 
Comparator Agent  placebo  2ml normal saline IV route 5 minute before spinal anaesthesia 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  Patients of age 18-45 years, either sex, ASA physical status I & II undergoing elective lower limb orthopaedic surgeries under spinal anaesthesia will be included in this
study. 
 
ExclusionCriteria 
Details  Exclusion criteria:

(i) Patients having contraindications for spinal anaesthesia like lack of consent, raised intra cranial tension, infection at local site, severe aortic stenosis, coagulopathy, cardiovascular instability.

(ii) Patients with known allergy to study drugs

(iii) Patients with BMI > 30 kg/m²

(iv) Patients having height < 150 cm

(v) Patients ASA physical status III or more

(vi) Patients having major cardiovascular,
respiratory, renal, hepatic, metabolic, neurological or endocrine diseases.

(vii) Patients with glaucoma

(viii) Patients receiving any antihypertensive, vasodilator, antiarrhythmic or antiemetic
agents

(ix) Patients requiring general anaesthesia 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
incidence of hypotension intraoperatively after giving spinal anaesthesia  19 months 
 
Secondary Outcome  
Outcome  TimePoints 
incidence of bradycardia, total phenylephrine requirement and total fluid requirement in the intraoperative period.   19 months 
 
Target Sample Size   Total Sample Size="123"
Sample Size from India="123" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   25/05/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none yet  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This prospective, parallel group, double blind placebo-controlled study will be conducted on 123 patients of age 18-45 years, either sex, ASA physical status I & II undergoing elective lower limb orthopaedic surgeries under spinal anaesthesia. Patients will be randomly divided into 3 groups, Group O Group G and Group N. Patients in Group O will receive inj. ondansetron 4 mg (2 ml) IV, patients in Group G will receive inj. glycopyrrolate 0.2 mg (2 ml) IV and patients in Group N will receive normal saline 2 ml IV, 5 minutes prior to spinal anaesthesia. Heart rate, blood pressure, phenylephrine and intravenous fluid requirement will be recorded intraoperatively and postoperatively. The study will be conducted to compare ondansetron and glycopyrrolate in prevention of spinal induced hypotension and bradycardia in patients undergoing lower limb orthopaedic surgery.   
Close